Compare Kohl's Corporation (KSS) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kohl's Corporation vs Sanofi SA — how do they compare? Kohl's Corporation trades at $17.41 (market cap $1.99B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Sanofi SA is far larger — about 52.7× Kohl's Corporation's market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| KSS | SNY | |
|---|---|---|
Market Cap | $1.99B | $104.83B |
Sector | Consumer Cyclical | Health |
52-Week High | $24.71 | $52.34 |
52-Week Low | $10.42 | $41.33 |
Enterprise Value | $8.10B | $121.32B |
Dividend Yield | 2.85% | 5.5% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kohl's Corporation
Kohl's operates 1,165 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 27% of its 2021 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
Read more on KSS →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
